CAS: 1020251-53-9 - Xanthoanthrafil

Fórmula: C₁₉H₂₃N₃O₆

InChI: InChI=1S/C19H23N3O6/c1-12(11-23)21-16-6-5-14(22(25)26)9-15(16)19(24)20-10-13-4-7-17(27-2)18(8-13)28-3/h4-9,12,21,23H,10-11H2,1-3H3,(H,20,24)

Chave InChI: InChIKey=ZISFCTXLAXIEMV-UHFFFAOYSA-N

SMILES: O=C(NCC1=CC=C(OC)C(OC)=C1)C2=CC(=CC=C2NC(C)CO)N(=O)=O

Sinónimos:

• Benzamide, N-[(3,4-dimethoxyphenyl)methyl]-2-[(2-hydroxy-1-methylethyl)amino]-5-nitro-
• N-[(3,4-Dimethoxyphenyl)methyl]-2-[(2-hydroxy-1-methylethyl)amino]-5-nitrobenzamide
• Xanthoanthrafil
• Benzamidenafil

Benzamide, N-[(3,4-dimethoxyphenyl)methyl]-2-[(2-hydroxy-1-methylethyl)amino]-5-nitro-

CAS: 1020251-53-9

• Fórmula: C₁₉H₂₃N₃O₆
• Cor e Forma: Solid
• Peso molecular: 389.4024

Xanthoanthrafil (Benzamidenafil)

CAS: 1020251-53-9

• Fórmula: C₁₉H₂₃N₃O₆
• Cor e Forma: Pale Yellow Solid
• Peso molecular: 389.41

rac Xanthoanthrafil (>90%)

CAS: 1020251-53-9

Applications Phosphodiesterase-5 (PDE-5) inhibitor, found in supplements aimed to enhance male sexual function. References Zou, …

• Fórmula: C₁₉H₂₃N₃O₆
• Pureza: >90%
• Cor e Forma: Light Yellow To Dark Yellow
• Peso molecular: 389.40

rac Xanthoanthrafil

CAS: 1020251-53-9

Rac Xanthoanthrafil is a drug that is used in the treatment of metabolic disorders. It …

• Fórmula: C₁₉H₂₃N₃O₆
• Pureza: Min. 98 Area-%
• Cor e Forma: Powder
• Peso molecular: 389.4 g/mol